Acumen Pharmaceuticals, Inc. (ABOS) Options Statistics & Positioning

Acumen Pharmaceuticals, Inc. (ABOS) options trade at a 30-day at-the-money implied volatility of 106.0%, an IV rank of 39 out of 100 over the past year. The options market prices a ±$0.38 (±14.7%) move in ABOS for the front expiration. Max pain sits at $2.5 and the put/call open interest ratio is 0.04. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close

$2.57

52-week range

$1.22 – $3.40

ATM IV (30d)

106.0%

IV rank

39 / 100

Low

Expected move

±$0.38 (±14.7%)

Put/call OI

0.04

Call-heavy

Max pain

$2.5

↓ 2.7% below close

Next earnings

Aug 12, 2026

Most Active ABOS Contracts

Contract	Expiration	DTE	Last	IV	Volume
ABOS $2.5 call	Jul 17, 2026	7d	$0.13	106.0%	10
ABOS $5 call	Jul 17, 2026	7d	$0.15	405.5%	2
ABOS $2.5 put	Jul 17, 2026	7d	$0.09	148.1%	1

See all active ABOS contracts →

Explore ABOS Options Statistics

ABOS Implied Volatility

106.0% ATM IV (30d)

An IV rank of 39 places implied volatility in the lower part of its 52-week range.

Full implied volatility analysis →

ABOS Open Interest

0.04 put/call OI ratio

2,239 calls and 98 puts outstanding across all expirations.

Full open interest analysis →

ABOS Max Pain

$2.5 max pain

2.7% below the last close — see how max pain has moved over the past year.

Full max pain analysis →

ABOS Gamma Exposure

$698.39K net GEX

Positive dealer gamma — hedging currently leans against price swings.

Full gamma exposure analysis →

ABOS Options Volume

13 contracts traded

Put/call volume ratio 0.08 — plus contracts running far above their usual volume.

Full volume & flow analysis →

ABOS Most Active Options

$2.5 top volume strike

The 25 most actively traded ABOS contracts with price, IV, greeks, and volume vs. average.

Full active contracts analysis →

Upcoming Earnings

ABOS's next expected earnings date is Aug 12, 2026. Options currently price a ±$0.38 (±14.7%) move for the front expiration.

Explore the payoff profile of option on ABOS for free

Build multi-leg ABOS strategies, visualize payoffs, and scan the full US options universe with OptiView.

Open ABOS in the platform Scan options

ABOS Options FAQ

When is ABOS's next earnings date?

ABOS's next expected earnings date is Aug 12, 2026. Options currently price a ±$0.38 (±14.7%) move for the front expiration.

How often is ABOS options data on this page updated?

All ABOS statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.

Where can I see ABOS max pain, open interest, and implied volatility in detail?

OptiView publishes dedicated ABOS pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.